{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:48:32Z","timestamp":1782290912798,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>New evidence suggests a relatively high prevalence of occult cardiac amyloidosis (CA) among patients with aortic stenosis (AS). While transcatheter aortic valve replacement (TAVR) is an established treatment for AS, the impact of concomitant CA on long-term outcomes remains unclear. We conducted a systematic review and meta-analysis to evaluate survival and procedural outcomes of TAVR in AS patients with and without CA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, Scopus, Web of Science, Google Scholar, and the Cochrane Library were searched through 21 April 2026. Studies comparing outcomes of TAVR in patients with and without CA and reporting Kaplan\u2013Meier survival curves were included. Individual patient survival data were extracted from Kaplan\u2013Meier curves and reconstructed for pooled analysis. Secondary outcomes were analyzed using random-effects meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven studies including 2747 patients were analyzed. In the primary analysis, which included both definitive and probability-based definitions of CA, CA was associated with increased all-cause mortality following TAVR (HR: 1.58; 95% CI 1.23, 2.03;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, in a sensitivity analysis restricted to studies with confirmed CA, this association was no longer significant (HR: 1.32, 95% CI 0.84, 2.07,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.226). There were no significant differences in pacemaker implantation (OR: 1.33; 95% CI 0.69, 2.56;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.40) or more than mild aortic regurgitation (OR: 0.96; 95% CI 0.25, 3.78;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.96).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The association between CA mortality after TAVR in AS patients is highly dependent on how CA is defined. While analyses including screening-based cohorts suggest increased risk, this was not observed in analyses of studies with confirmed CA. These findings highlight the impact of differing diagnostic approaches in CA and underscore the need for future studies to use standardized criteria and prospective designs to clarify the independent prognostic role of confirmed CA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-026-00762-3","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:15:28Z","timestamp":1782288928000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of cardiac amyloidosis on survival in aortic stenosis patients undergoing TAVR: a systematic review and reconstructed time-to-event meta-analysis"],"prefix":"10.1186","volume":"78","author":[{"given":"Omar","family":"Almaadawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8880-5051","authenticated-orcid":false,"given":"Naydeen","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elbataa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belal","family":"Mohamed Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0959-9046","authenticated-orcid":false,"given":"Menna","family":"Sarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Mohyeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Asad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buseyna","family":"Dahik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Ismael Elnady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ashraf Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elshahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.cjca.2014.03.022","volume":"30","author":"B Iung","year":"2014","unstructured":"Iung B, Vahanian A (2014) Epidemiology of acquired valvular heart disease. Can J Cardiol 30:962\u2013970. https:\/\/doi.org\/10.1016\/j.cjca.2014.03.022","journal-title":"Can J Cardiol"},{"key":"762_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1055\/s-0042-1758382","volume":"31","author":"A Kodra","year":"2022","unstructured":"Kodra A, Kim M (2022) Calcific Aortic Valve Stenosis with Aging and Current Development in its Pathophysiology. Int J Angiol 31:229\u2013231. https:\/\/doi.org\/10.1055\/s-0042-1758382","journal-title":"Int J Angiol"},{"key":"762_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2022.06.003","volume":"355","author":"E Boakye","year":"2022","unstructured":"Boakye E, Dardari Z, Obisesan OH et al (2022) Sex-and race-specific burden of aortic valve calcification among older adults without overt coronary heart disease: The Atherosclerosis Risk in Communities Study. Atherosclerosis 355:68\u201375. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2022.06.003","journal-title":"Atherosclerosis"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.jacc.2020.12.052","volume":"77","author":"MB Leon","year":"2021","unstructured":"Leon MB, Mack MJ, Hahn RT et al (2021) Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk. JACC 77:1149\u20131161. https:\/\/doi.org\/10.1016\/j.jacc.2020.12.052","journal-title":"JACC"},{"key":"762_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/24748706.2020.1828669","volume":"4","author":"M Megaly","year":"2020","unstructured":"Megaly M, Sorajja P, Garcia S et al (2020) Cardiac Amyloidosis is Underdiagnosed in Patients Undergoing Transcatheter Aortic Valve Replacement. Struct Heart 4:512\u2013514. https:\/\/doi.org\/10.1080\/24748706.2020.1828669","journal-title":"Struct Heart"},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/S0140-6736(06)69208-8","volume":"368","author":"VT Nkomo","year":"2006","unstructured":"Nkomo VT, Gardin JM, Skelton TN et al (2006) Burden of valvular heart diseases: a population-based study. Lancet 368:1005\u20131011. https:\/\/doi.org\/10.1016\/S0140-6736(06)69208-8","journal-title":"Lancet"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.rec.2017.05.036","volume":"70","author":"E Gonz\u00e1lez-L\u00f3pez","year":"2017","unstructured":"Gonz\u00e1lez-L\u00f3pez E, L\u00f3pez-Sainz \u00c1, Garcia-Pavia P (2017) Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope. Rev Esp Cardiol (Engl Ed) 70:991\u20131004. https:\/\/doi.org\/10.1016\/j.rec.2017.05.036","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"e005066","DOI":"10.1161\/CIRCIMAGING.116.005066","volume":"9","author":"TA Treibel","year":"2016","unstructured":"Treibel TA, Fontana M, Gilbertson JA et al (2016) Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement. Circ Cardiovasc Imaging 9:e005066. https:\/\/doi.org\/10.1161\/CIRCIMAGING.116.005066","journal-title":"Circ Cardiovasc Imaging"},{"key":"762_CR9","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B et al (2018) Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 379:1007\u20131016. https:\/\/doi.org\/10.1056\/NEJMoa1805689","journal-title":"N Engl J Med"},{"key":"762_CR10","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1093\/eurheartj\/ehaa170","volume":"41","author":"PR Scully","year":"2020","unstructured":"Scully PR, Patel KP, Treibel TA et al (2020) Prevalence and outcome of dual aortic stenosis and cardiac amyloid pathology in patients referred for transcatheter aortic valve implantation. Eur Heart J 41:2759\u20132767. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa170","journal-title":"Eur Heart J"},{"key":"762_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.hjc.2021.11.001","volume":"64","author":"JS-Y Ho","year":"2022","unstructured":"Ho JS-Y, Kor Q, Kong WK et al (2022) Prevalence and outcomes of concomitant cardiac amyloidosis and aortic stenosis: A systematic review and meta-analysis. Hellenic J Cardiol 64:67\u201376. https:\/\/doi.org\/10.1016\/j.hjc.2021.11.001","journal-title":"Hellenic J Cardiol"},{"key":"762_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2025.103240","author":"O Almaadawy","year":"2025","unstructured":"Almaadawy O, Mostafa N, Sarhan M et al (2025) D-108 | outcomes post TAVI in aortic stenosis patients with cardiac amyloidosis: a reconstructed time-to-event meta-analysis. J Soc Cardiovasc Angiogr Interv. https:\/\/doi.org\/10.1016\/j.jscai.2025.103240","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","volume":"68","author":"RH Falk","year":"2016","unstructured":"Falk RH, Alexander KM, Liao R, Dorbala S (2016) AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and Therapy. J Am Coll Cardiol 68:1323\u20131341. https:\/\/doi.org\/10.1016\/j.jacc.2016.06.053","journal-title":"J Am Coll Cardiol"},{"key":"762_CR14","doi-asserted-by":"publisher","first-page":"e221082","DOI":"10.1148\/radiol.221082","volume":"306","author":"YM Khor","year":"2023","unstructured":"Khor YM, Cuddy SAM, Singh V et al (2023) 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac Amyloidosis. Radiology 306:e221082. https:\/\/doi.org\/10.1148\/radiol.221082","journal-title":"Radiology"},{"key":"762_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560. https:\/\/doi.org\/10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"762_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/096228029300200202","volume":"2","author":"JL Fleiss","year":"1993","unstructured":"Fleiss JL (1993) The statistical basis of meta-analysis. Stat Methods Med Res 2:121\u2013145. https:\/\/doi.org\/10.1177\/096228029300200202","journal-title":"Stat Methods Med Res"},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.acvd.2024.04.007","volume":"117","author":"J Costa","year":"2024","unstructured":"Costa J, El-Ali A, Morland D et al (2024) Cardiac amyloidosis prevalence and 1-year outcome in patients with aortic stenosis undergoing transaortic valve implantation: Findings from the CAMPOS-TAVI study. Arch Cardiovasc Dis 117:461\u2013469. https:\/\/doi.org\/10.1016\/j.acvd.2024.04.007","journal-title":"Arch Cardiovasc Dis"},{"key":"762_CR18","doi-asserted-by":"publisher","first-page":"e030271","DOI":"10.1161\/JAHA.123.030271","volume":"12","author":"S Dobner","year":"2023","unstructured":"Dobner S, Pilgrim T, Hagemeyer D et al (2023) Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. J Am Heart Assoc 12:e030271. https:\/\/doi.org\/10.1161\/JAHA.123.030271","journal-title":"J Am Heart Assoc"},{"key":"762_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/ehjdh\/ztae022","volume":"5","author":"M Pereyra Pietri","year":"2024","unstructured":"Pereyra Pietri M, Farina JM, Mahmoud AK et al (2024) The prognostic value of artificial intelligence to predict cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J Digit Health 5:295\u2013302. https:\/\/doi.org\/10.1093\/ehjdh\/ztae022","journal-title":"Eur Heart J Digit Health"},{"key":"762_CR20","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ejhf.1974","volume":"23","author":"H Rosenblum","year":"2021","unstructured":"Rosenblum H, Masri A, Narotsky DL et al (2021) Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis. Eur J Heart Fail 23:250\u2013258. https:\/\/doi.org\/10.1002\/ejhf.1974","journal-title":"Eur J Heart Fail"},{"key":"762_CR21","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1002\/ehf2.14709","volume":"11","author":"BE Beuthner","year":"2024","unstructured":"Beuthner BE, Elkenani M, Evert K et al (2024) Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement. ESC Heart Fail 11:1636\u20131646. https:\/\/doi.org\/10.1002\/ehf2.14709","journal-title":"ESC Heart Fail"},{"key":"762_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.carrev.2024.11.008","volume":"73","author":"J Maenza","year":"2025","unstructured":"Maenza J, Chopra L, Mannina C et al (2025) Effect of cardiac amyloidosis on outcomes in transcatheter aortic valve replacement in low-flow low-gradient aortic stenosis. Cardiovasc Revasc Med 73:82\u201384. https:\/\/doi.org\/10.1016\/j.carrev.2024.11.008","journal-title":"Cardiovasc Revasc Med"},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"iii7","DOI":"10.1093\/eurheartjsupp\/suaf036","volume":"27","author":"M Grasso","year":"2025","unstructured":"Grasso M, Cavaliere C, Vilardo V et al (2025) Present and future of endomyocardial biopsy in cardiac amyloidosis. Eur Heart J Suppl 27:iii7\u2013iii12. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suaf036","journal-title":"Eur Heart J Suppl"},{"key":"762_CR24","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.3390\/biomedicines13051230","volume":"13","author":"DE Movila","year":"2025","unstructured":"Movila DE, Motofelea AC, Cozma D et al (2025) Cardiac Amyloidosis: A Narrative Review of Diagnostic Advances and Emerging Therapies. Biomedicines 13:1230. https:\/\/doi.org\/10.3390\/biomedicines13051230","journal-title":"Biomedicines"},{"key":"762_CR25","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1186\/s12872-025-05353-9","volume":"25","author":"A Shubietah","year":"2025","unstructured":"Shubietah A, Owda D, Rakab MS et al (2025) Nationwide patterns of cardiac-related mortality in amyloidosis cases: an epidemiologic study. BMC Cardiovasc Disord 25:907. https:\/\/doi.org\/10.1186\/s12872-025-05353-9","journal-title":"BMC Cardiovasc Disord"},{"key":"762_CR26","doi-asserted-by":"publisher","first-page":"100720","DOI":"10.1016\/j.blre.2020.100720","volume":"45","author":"C Varga","year":"2021","unstructured":"Varga C, Dorbala S, Lousada I et al (2021) The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types. Blood Rev 45:100720. https:\/\/doi.org\/10.1016\/j.blre.2020.100720","journal-title":"Blood Rev"},{"key":"762_CR27","doi-asserted-by":"publisher","first-page":"A4366350","DOI":"10.1161\/circ.152.suppl_3.4366350","volume":"152","author":"A Mohamed","year":"2025","unstructured":"Mohamed A, Basali D, Zou Y et al (2025) Abstract 4366350: Ten-Year Survival in AL Cardiac Amyloidosis: Does Mayo Staging still matter in the Recent era? Circulation 152:A4366350\u2013A4366350. https:\/\/doi.org\/10.1161\/circ.152.suppl_3.4366350","journal-title":"Circulation"},{"key":"762_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","volume":"140","author":"T Lane","year":"2019","unstructured":"Lane T, Fontana M, Martinez-Naharro A et al (2019) Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. Circulation 140:16\u201326. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038169","journal-title":"Circulation"},{"key":"762_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40119-021-00219-5","volume":"10","author":"MH Rozenbaum","year":"2021","unstructured":"Rozenbaum MH, Large S, Bhambri R et al (2021) Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review. Cardiol Ther 10:141\u2013159. https:\/\/doi.org\/10.1007\/s40119-021-00219-5","journal-title":"Cardiol Ther"},{"key":"762_CR30","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.3390\/jcm15083037","volume":"15","author":"S Bukhari","year":"2026","unstructured":"Bukhari S (2026) Artificial Intelligence in Cardiac Amyloidosis: A State-of-the-Art Review. J Clin Med 15:3037. https:\/\/doi.org\/10.3390\/jcm15083037","journal-title":"J Clin Med"},{"key":"762_CR31","doi-asserted-by":"publisher","first-page":"e036533","DOI":"10.1161\/JAHA.124.036533","volume":"14","author":"M Grogan","year":"2025","unstructured":"Grogan M, Lopez-Jimenez F, Guthrie S et al (2025) Value of Artificial Intelligence for Enhancing Suspicion of Cardiac Amyloidosis Using Electrocardiography and Echocardiography: A Narrative Review. J Am Heart Assoc 14:e036533. https:\/\/doi.org\/10.1161\/JAHA.124.036533","journal-title":"J Am Heart Assoc"},{"key":"762_CR32","doi-asserted-by":"publisher","first-page":"4090","DOI":"10.1093\/eurheartj\/ehaf387","volume":"46","author":"JA Slivnick","year":"2025","unstructured":"Slivnick JA, Hawkes W, Oliveira J et al (2025) Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J 46:4090\u20134101. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf387","journal-title":"Eur Heart J"},{"key":"762_CR33","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.mayocp.2021.04.023","volume":"96","author":"M Grogan","year":"2021","unstructured":"Grogan M, Lopez-Jimenez F, Cohen-Shelly M et al (2021) Artificial Intelligence-Enhanced Electrocardiogram for the Early Detection of Cardiac Amyloidosis. Mayo Clin Proc 96:2768\u20132778. https:\/\/doi.org\/10.1016\/j.mayocp.2021.04.023","journal-title":"Mayo Clin Proc"},{"key":"762_CR34","doi-asserted-by":"publisher","first-page":"euaf085.237","DOI":"10.1093\/europace\/euaf085.237","volume":"27","author":"C Guenancia","year":"2025","unstructured":"Guenancia C, Lequeux B, Amara W et al (2025) Management of rhythm and conduction disorders in cardiac amyloidosis: a French nationwide Delphi study. Europace 27:euaf085.237. https:\/\/doi.org\/10.1093\/europace\/euaf085.237","journal-title":"Europace"},{"key":"762_CR35","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","volume":"74","author":"J Ternacle","year":"2019","unstructured":"Ternacle J, Krapf L, Mohty D et al (2019) Aortic Stenosis and Cardiac Amyloidosis: JACC Review Topic of the Week. J Am Coll Cardiol 74:2638\u20132651. https:\/\/doi.org\/10.1016\/j.jacc.2019.09.056","journal-title":"J Am Coll Cardiol"},{"key":"762_CR36","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3390\/jcm14020408","volume":"14","author":"JA Parada-Barcia","year":"2025","unstructured":"Parada-Barcia JA, Barreiro-P\u00e9rez M, Baz JA et al (2025) Impact of Echocardiographic Cardiac Damage Staging on Mortality and Heart Failure Hospitalizations in Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement. J Clin Med 14:408. https:\/\/doi.org\/10.3390\/jcm14020408","journal-title":"J Clin Med"},{"key":"762_CR37","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2215\/CJN.08720811","volume":"7","author":"L Lobato","year":"2012","unstructured":"Lobato L, Rocha A (2012) Transthyretin amyloidosis and the kidney. Clin J Am Soc Nephrol 7:1337\u20131346. https:\/\/doi.org\/10.2215\/CJN.08720811","journal-title":"Clin J Am Soc Nephrol"},{"key":"762_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.mayocp.2019.02.012","volume":"94","author":"J Dang","year":"2019","unstructured":"Dang J, Abulizi M, Moktefi A et al (2019) Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis. Mayo Clin Proc 94:961\u2013975. https:\/\/doi.org\/10.1016\/j.mayocp.2019.02.012","journal-title":"Mayo Clin Proc"},{"key":"762_CR39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jacc.2012.07.003","volume":"60","author":"P G\u00e9n\u00e9reux","year":"2012","unstructured":"G\u00e9n\u00e9reux P, Webb JG, Svensson LG et al (2012) Vascular Complications After Transcatheter Aortic Valve Replacement: Insights From the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial. J Am Coll Cardiol 60:1043\u20131052. https:\/\/doi.org\/10.1016\/j.jacc.2012.07.003","journal-title":"J Am Coll Cardiol"},{"key":"762_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jcin.2018.11.008","volume":"12","author":"SV Arnold","year":"2019","unstructured":"Arnold SV, Zhang Y, Baron SJ et al (2019) Impact of Short-Term Complications on Mortality and Quality of Life after TAVR. JACC Cardiovasc Interv 12:362\u2013369. https:\/\/doi.org\/10.1016\/j.jcin.2018.11.008","journal-title":"JACC Cardiovasc Interv"},{"key":"762_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/14779072.2026.2636590","volume":"24","author":"A Elazab","year":"2026","unstructured":"Elazab A, Hageen AW, Elbataa A et al (2026) The efficacy and safety of cerebral embolic protection devices in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials. Expert Rev Cardiovasc Ther 24:253\u2013271. https:\/\/doi.org\/10.1080\/14779072.2026.2636590","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"762_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000001263","author":"H Elbenawi","year":"2026","unstructured":"Elbenawi H, Mostafa N, Abdelgalil MS et al (2026) Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis and Prior Mediastinal Radiation: A Meta-Analysis of Short-Term and 1-Year Outcomes. Cardiol Rev. https:\/\/doi.org\/10.1097\/CRD.0000000000001263","journal-title":"Cardiol Rev"},{"key":"762_CR43","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1161\/CIRCULATIONAHA.117.028352","volume":"136","author":"V Auffret","year":"2017","unstructured":"Auffret V, Puri R, Urena M et al (2017) Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives. Circulation 136:1049\u20131069. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028352","journal-title":"Circulation"},{"key":"762_CR44","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jacc.2011.11.045","volume":"59","author":"H Jilaihawi","year":"2012","unstructured":"Jilaihawi H, Kashif M, Fontana G et al (2012) Cross-Sectional Computed Tomographic Assessment Improves Accuracy of Aortic Annular Sizing for Transcatheter Aortic Valve Replacement and Reduces the Incidence of Paravalvular Aortic Regurgitation. J Am Coll Cardiol 59:1275\u20131286. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.045","journal-title":"J Am Coll Cardiol"},{"key":"762_CR45","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.jcin.2012.04.003","volume":"5","author":"L Buellesfeld","year":"2012","unstructured":"Buellesfeld L, Grube E (2012) A permanent solution for a temporary problem: transcatheter valve-in-valve implantation for failed transcatheter aortic valve replacement. JACC Cardiovasc Interv 5:578\u2013581. https:\/\/doi.org\/10.1016\/j.jcin.2012.04.003","journal-title":"JACC Cardiovasc Interv"},{"key":"762_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jacc.2013.02.088","volume":"62","author":"J-M Sinning","year":"2013","unstructured":"Sinning J-M, Vasa-Nicotera M, Chin D et al (2013) Evaluation and Management of Paravalvular Aortic Regurgitation After Transcatheter Aortic Valve Replacement. J Am Coll Cardiol 62:11\u201320. https:\/\/doi.org\/10.1016\/j.jacc.2013.02.088","journal-title":"J Am Coll Cardiol"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-026-00762-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00762-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:15:30Z","timestamp":1782288930000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43044-026-00762-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1186\/s43044-026-00762-3","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"31 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}